Researcher.Life Logo

Journal of Clinical Immunology : Impact Factor & More

eISSN: 1573-2592pISSN: 0271-9142

Aims and Scope of Journal of Clinical Immunology

The Journal of Clinical Immunology (print: ISSN 0271-9142, electronic: ISSN 1573-2592) is a bimonthly medical journal published by Springer since 1981. It focuses on research investigating immunology—via basic research, translational research, or clinical studies—and diseases related to the immune system. According to the 2019 Journal Citation Reports, its impact factor is 6.780. The editor in chief is Vincent Bonagura (Northwell Health). Less

Key Metrics

CiteScore
11.4
Eigenfactor
0.005 - 0.01
H-Index
107
Impact Factor
5 - 10
SJR
Q1Immunology
SNIP
2.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Clinical Immunology

Journal of Clinical Immunology Journal Specifications

Overview
Publisher SPRINGER/PLENUM PUBLISHERS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Clinical Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Clinical Immunology

Autoimmune Retinopathy Complicating TLR7-related Monogenic Interferonopathy.
  • 20 May 2026
  • Journal of clinical immunology
Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report.
  • 19 May 2026
  • Journal of clinical immunology
Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3.
  • 9 May 2026
  • Journal of clinical immunology
Comprehensive Profiling of T- and B-Cell Receptor Repertoires Demonstrates Impaired Developmental and Activation of Adaptive Immunity in DOCK8 Deficiency.
  • 6 May 2026
  • Journal of clinical immunology
First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults.
  • 29 Apr 2026
  • Journal of clinical immunology
Immune Dysregulation and Persistent Symptoms: Insights into T Cell Dynamics in Post-COVID among Athletes from the CoSmo-S Study.
  • 27 Apr 2026
  • Journal of clinical immunology
Autoimmune Retinopathy Complicating TLR7-related Monogenic Interferonopathy.
  • 20 May 2026
  • Journal of clinical immunology
Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report.
  • 19 May 2026
  • Journal of clinical immunology
Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3.
  • 9 May 2026
  • Journal of clinical immunology
Comprehensive Profiling of T- and B-Cell Receptor Repertoires Demonstrates Impaired Developmental and Activation of Adaptive Immunity in DOCK8 Deficiency.
  • 6 May 2026
  • Journal of clinical immunology
First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults.
  • 29 Apr 2026
  • Journal of clinical immunology
Immune Dysregulation and Persistent Symptoms: Insights into T Cell Dynamics in Post-COVID among Athletes from the CoSmo-S Study.
  • 27 Apr 2026
  • Journal of clinical immunology

FAQs on Journal of Clinical Immunology